CLINICAL_TRIALS
trial_result
· 2020-10-30
Clinical Trial Update: Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD [Phase 2]
Summary
Phase 2 randomized, double-blind, placebo-controlled pilot trial of MDMA-assisted therapy for PTSD has completed and results were posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lykos Therapeutics | Conditions: Posttraumatic Stress Disorder (PTSD) | Phase 2 | Status: COMPLETED | Results posted: 2020-10-30